Study Information

Title: A Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer External
Status: Recruiting participants
Conditions: Breast Cancer
Interventions: Drug: GDC-0032; Drug: GDC-0032; Drug: Docetaxel; Drug: Paclitaxel
Health Topics: Breast Cancer

Contact Information